Economic Evaluation of Trimetazidine in the Management of Chronic Stable Angina in Greece

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.869
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Acceptability of Trimetazidine Modified-Release 80 Mg Once Daily Versus Trimetazidine Modified-Release 35 Mg Twice Daily in Stable Angina Pectoris

Cardiology and Therapy
2018English

Economic Evaluation of Intravenous Iron Treatments in the Management of Anemia Patients in Greece

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2012English

MicroRNA-155 in Patients With Chronic Stable Angina

Annals of Applied Bio-Sciences
2017English

The Prevalence of Weekly Angina Among Patients With Chronic Stable Angina in Primary Care Practices

Archives of Internal Medicine
2009English

PSY35 Economic Evaluation of Lenalidomide in the Management of Previously Treated Multiple Myeloma (PTMM) Patients in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

PCN38 Economic Evaluation of Darbepoetin Alpha in the Management of Patients With Chemotherapy Induced Anemia (CIA) in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Calcium Antagonist Drugs in Chronic Stable Angina. Comparison of Verapamil and Nifedipine.

Heart
Cardiovascular MedicineCardiology
1981English

Evaluation of Local Carotid Stiffness and Inflammatory Biomarkers in Stable Angina Pectoris

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2017English

Ranolazine for the Symptomatic Treatment of Patients With Chronic Angina Pectoris in Greece: A Cost-Utility Study

BMC Health Services Research
Health Policy
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy